MENU
+Compare
ZLDAF
Stock ticker: OTC
AS OF
Oct 6 closing price
Price
$0.21
Change
-$0.05 (-19.23%)
Capitalization
2.99M

ZLDAF Zelira Therapeutics Ltd. Forecast, Technical & Fundamental Analysis

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia... Show more

ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ZLDAF with price predictions
Oct 07, 2025

ZLDAF saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for ZLDAF moved out of overbought territory on October 06, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 38 similar instances where the indicator exited the overbought zone. In of the 38 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ZLDAF as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ZLDAF turned negative on October 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

ZLDAF moved below its 50-day moving average on October 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZLDAF crossed bearishly below the 50-day moving average on October 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

ZLDAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZLDAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. ZLDAF's P/S Ratio (5000.000) is very high in comparison to the industry average of (342.085).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZLDAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 St George’s Terrace
Phone
+61 865580886
Employees
8
Web
https://www.zeliratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICG1.81N/A
+0.27%
Intchains Group Limited
WSO396.420.08
+0.02%
Watsco
BFH55.02-0.40
-0.72%
Bread Financial Holdings
KXIN0.66-0.01
-0.96%
Kaixin Holdings
EVTL5.87-0.08
-1.34%
Vertical Aerospace Ltd

ZLDAF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
VSTM - ZLDAF
47%
Loosely correlated
+4.53%
QLGN - ZLDAF
28%
Poorly correlated
N/A
GNLX - ZLDAF
25%
Poorly correlated
+3.74%
SNSE - ZLDAF
22%
Poorly correlated
+18.36%
PRLD - ZLDAF
11%
Poorly correlated
-1.37%
More